What is One BIO?
One BIO operates at the intersection of biotechnology and consumer health, specializing in the extraction of short-chain fibers from plants. By making these essential nutrients highly consumable and effective, the company aims to invigorate the human microbiome and bolster immune system function. Positioned as a disruptor in the nutrition space, One BIO is actively working to eradicate inflammatory diseases by reshaping how everyday products are formulated. Its market position is bolstered by a commitment to scientific rigor and the development of scalable solutions that bridge the gap between advanced biotech research and daily dietary habits.
How much funding has One BIO raised?
One BIO has raised a total of $27M across 1 funding round:
Series A
$27M
Series A (2024): $27M with participation from Skyviews Life Science, ACRE, Bayer, Better, iSelect, Alpha Edison, and Morado
Key Investors in One BIO
Skyviews Life Science
A privately held advisory firm that identifies investment opportunities at the intersection of biotechnology, advanced nutrition, and digital health to enhance individual quality of life.
Bayer
A global enterprise with core competencies in health care and agriculture, focusing on innovative medicines, self-care brands, and digital farming tools to support sustainable food security.
Alpha Edison
An investment firm that collaborates with entrepreneurs to create companies that tap into new markets, specifically focusing on technology-driven solutions for shifting consumer behaviors.
What's next for One BIO?
With this major enterprise-level funding, One BIO is well-positioned to accelerate its research and development pipeline and expand its strategic partnerships. The company is expected to focus on scaling its production capabilities to meet the growing demand for functional, fiber-rich food solutions. By leveraging its recent capital, One BIO will likely prioritize clinical validation of its fiber extraction technology and explore new distribution channels to integrate its products into the broader consumer health market. The firm's long-term strategy remains centered on transforming the global approach to nutrition and establishing a new standard for preventative health through diet.
See full One BIO company page
